2018 Speakers


Keynote Speaker at 2018 Conference

2018 Conference Speakers

Jerel Banks, M.D., Ph.D.

Jerel Banks, M.D., Ph.D.

Read more

Chief Investment Officer, NantVentures

Paul Biondi

Paul Biondi

Read more

SVP, Head of Business Development, BMS

Katherine Bowdish

Katherine Bowdish

Read more

Vice President Global R&D and Head of Sunrise Ventures, Sanofi U.S.

Daniel Bradbury

Daniel Bradbury

Read more

Managing Member, BioBrit, LLC

Paola Casarosa

Paola Casarosa

Read more

Corporate Vice President Business Development & Licensing, Boehringer Ingelheim

Hannah Chang

Hannah Chang

Read more

Investment Director, Wu Capital

Jon Edwards

Jon Edwards

Read more

Principal, Medicxi

Dan Estes, Ph.D.

Dan Estes, Ph.D.

Read more

Partner, Frazier Healthcare Partners

Rich Heyman, PhD

Rich Heyman, PhD

Read more

Therapeutic Advisory Board, aTyr Pharma

Chris Haskell, Ph.D.

Chris Haskell, Ph.D.

Read more

Vice President and Head of the West Coast Innovation Center, Bayer

Natasha Hernday

Natasha Hernday

Read more

Senior VP Corporate Development, Seattle Genetics

John Hood

John Hood

Read more

Founder & CEO, Impact Biomedicines

David Kabakoff

David Kabakoff

Read more

Executive Director, Private Equity, Sofinnova Ventures

Balraj Kakkar

Balraj Kakkar

Read more

Managing Director, Life Sciences | Parthenon-EY, Ernst & Young LLP

Kim Kamdar, Ph.D.

Kim Kamdar, Ph.D.

Read more

Partner, Domain Associates

Syed Kazmi

Syed Kazmi

Read more

Executive Director of Business Development, Amgen

Chau Quang Khuong

Chau Quang Khuong

Read more

Private Equity Partner, Orbimed

Tomas Landh, MSc (Chem. Eng.), PhD

Tomas Landh, MSc (Chem. Eng.), PhD

Read more

Innovation Sourcing Vice President, Senior Principal Scientist R&D External Innovation Sourcing, Novo Nordisk A/S Denmark

Ji Li

Ji Li

Read more

Executive Vice President, Global Head of Business Development, BeiGene

Bill Mendez

Bill Mendez

Read more

Vice President Alliance Management, BD Strategy & Operations, Pharma R&D, GSK

David Moller, M.D.

David Moller, M.D.

Read more

Chief Scientific Officer, Sigilon Therapeutics

Ron Newbold

Ron Newbold

Read more

Senior Vice President and Head of US Business Development & Alliance Management, Otsuka America Pharmaceuticals

Oleg Nodelman

Oleg Nodelman

Read more

Founder and Managing Director, EcoR1

Carole Nuechterlein

Carole Nuechterlein

Read more

Head, Roche Venture Fund

Michael O’Donnell

Michael O’Donnell

Read more

Partner, Morrison & Foester

Catherine Oyler

Catherine Oyler

Read more

Global Head, Strategy & Operations, Johnson & Johnson External Innovation

Andrew Schwab

Andrew Schwab

Read more

Founder & Managing Partner, 5AM Ventures

Armen Shanafelt, Ph.D.

Armen Shanafelt, Ph.D.

Read more

General Partner, Lilly Ventures

Jason Skolnik

Jason Skolnik

Read more

Corporate and Securities Partner, Wilson Sonsini Goodrick & Rosati

Bob Smith

Bob Smith

Read more

Senior Vice President, Global Gene Therapy Business, Rare Disease, Global Innovation Pharma, Pfizer Inc.

Avi Spier

Avi Spier

Read more

Director, NIBR BD&L, Search and Evaluation, Novartis

Kumar Srinivasan

Kumar Srinivasan

Read more

Vice President, Head of Scientific Partnering & Alliances, AstraZeneca

Bruce Steel

Bruce Steel

Read more

Founder and Managing Director, BioMed Ventures

Darryl Steensma

Darryl Steensma

Read more

Counsel, Latham & Watkins

Benjamin Thorner

Benjamin Thorner

Read more

Senior Vice President, Business Development and Licensing, Merck Research Laboratories

DA Wallach

DA Wallach

Read more

Recording Artist and Songwriter turned Investor, Inevitable Ventures

Jeffrey Warmke

Jeffrey Warmke

Read more

Senior Vice President, Daiichi Sankyo Group